Karolin Behringer

Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group

Karolin Behringer, Kai Breuer, Thorsten Reineke et al. · Journal of Clinical Oncology · 2005 · 298 citations · Full text

Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials

Karolin Behringer, Horst Mueller, Helen Goergen et al. · Journal of Clinical Oncology · 2012 · 253 citations

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

Karolin Behringer, Helen Goergen, Felicitas Hitz et al. · The Lancet · 2014 · 178 citations

Hematological Malignancy, Lymphoid Neoplasia, Ghsg Hd13 +10

No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group

Karolin Behringer, L. Wildt, Horst Mueller et al. · Annals of Oncology · 2010 · 165 citations · Full text

Lymphoid Neoplasia, Contraception, Hormonal Contraceptive +13

Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group

Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp et al. · Blood · 2014 · 136 citations